Hsbc Holdings PLC Vericel Corp Transaction History

Hsbc Holdings PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$32.52 - $52.33 $281,135 - $452,392	8,645 New	8,645 $449,000
Q4 2022 Feb 14, 2023	BUY	$17.65 - $27.37 $214,394 - $332,463	12,147 New	12,147 $319,000
Q2 2022 Aug 11, 2022	SELL	$22.88 - $39.45 $317,345 - $547,171	-13,870 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $193,150 - $263,852	6,095 Added 78.39%	13,870 $539,000
Q4 2021 Feb 11, 2022	BUY	$35.2 - $52.6 $84,163 - $125,766	2,391 Added 44.41%	7,775 $305,000
Q3 2021 Nov 12, 2021	SELL	$46.35 - $59.75 $24,797 - $31,966	-535 Reduced 9.04%	5,384 $264,000
Q2 2021 Aug 13, 2021	BUY	$47.2 - $67.81 $279,376 - $401,367	5,919 New	5,919 $310,000
Q3 2020 Nov 12, 2020	SELL	$14.68 - $19.12 $175,602 - $228,713	-11,962 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.5 - $15.82 $101,677 - $189,238	11,962 New	11,962 $165,000

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.